To conduct a randomized controlled clinical study of TTE with bedside transthoracic ultrasound in patients with non-cardiac surgery for hypotension in AICU

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076541

Enrollment

Unknown

Registered

2023-10-11

Start date

2023-10-16

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

Routine monitoring group:Routine monitoring indices (BP, HR, CVP, PPV, urine, drainage) were monitored and empirical volume supplementation/and different types of vasoactive drug applications (norepin

Ultrasound monitoring group:Admission to AICU stabilized for 10min, extubation stabilized for 10min, bedside transthoracic ultrasound TTE is used to monitor IVC-CI, FTc, GLS, SVR when the condition ch

according to the TTE monitoring indexes, the corresponding volume or/and selection of different kinds of vasoactive drugs are applied (norepinephrine, phenylephrine, ephedrine, dobutamine, etc.)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients undergoing non-cardiac surgery under general anesthesia; 2.Postoperative transfer to AICU; 3.Age = 18 years; 4.not limited to gender; 5.No precordial infection, rib fractures; 6.Agreed to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Poor image quality, poor echogenicity; 2.Those who can't cooperate and can't communicate.

Design outcomes

Primary

Measure	Time frame
Incidence and duration of hypotension;	—

Secondary

Measure	Time frame
Use of vasoactive drugs, including type, total amount, duration of use;Blood biochemical indexes (blood routine, biochemistry, BNP, TnT, inflammatory binomial, heparin-binding protein) 1 day before surgery, 1 day after surgery, and 3-7 days after surgery (1 day before discharge);Vital signs: SBP, DBP, MAP, SpO2, HR, RR, etCO2, PPV ;Bedside transthoracic ultrasound monitoring indices: IVC-CI, FTc, GLS, SVR;Management of postoperative complications and medication use;Length of AICU stay, postoperative hospitalization;Quality of postoperative recovery;	—

Measure

Time frame

Use of vasoactive drugs, including type, total amount, duration of use;Blood biochemical indexes (blood routine, biochemistry, BNP, TnT, inflammatory binomial, heparin-binding protein) 1 day before surgery, 1 day after surgery, and 3-7 days after surgery (1 day before discharge);Vital signs: SBP, DBP, MAP, SpO2, HR, RR, etCO2, PPV ;Bedside transthoracic ultrasound monitoring indices: IVC-CI, FTc, GLS, SVR;Management of postoperative complications and medication use;Length of AICU stay, postoperative hospitalization;Quality of postoperative recovery;

—

Countries

China

Contacts

Public ContactSun Yu'e

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

13913846977@126.com+86 139 1384 6977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026